No products in the cart.
TNFSF12-TNFSF13: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TNFSF12-TNFSF13. The page also collects GeneMedi’s different modalities and formats products for TNFSF12-TNFSF13 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TNFSF12-TNFSF13 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Secreted Protein/Potential Cytokines.
This gene encodes a member of the tumor necrosis factor superfamily. It encodes a hybrid protein composed of the cytoplasmic and transmembrane domains of family member 12 fused to the C-terminal domain of family member 13. The hybrid protein is membrane anchored and presents the receptor-binding domain of family member 13 at the cell surface. It stimulates cycling in T- and B-lymphoma cell lines. [provided by RefSeq, Jul 2008]
|
Target ID |
GM-SE0519
|
|
Target Name |
TNFSF12-TNFSF13
|
|
Gene ID |
407977
|
|
Gene Official Name |
TNFSF12-TNFSF13
|
|
Gene Alias |
TWE-PRIL
|
|
Protein Sub-location |
Secreted Protein/Potential Cytokines
|
|
Category |
|
Anti-TNFSF12-TNFSF13/ TWE-PRIL functional antibody for cell culture, ELISA & in-vivo assay| GMab
Pre-made anti-TNFSF12-TNFSF13 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TNFSF12-TNFSF13 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Filters
Sort results
Reset
Apply
Cat No. | Antibody Name | Format | Classified by tag | Order
|
|---|---|---|---|---|
Anti-TNFSF12-TNFSF13 monoclonal antibody |
mab |
FACS/Biofunctional Antibody |
